Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation

Kimberly Stegmaier(Broad Institute), Todd R. Golub(Broad Institute)
Nature Genetics
February 8, 2004
10.1038/ng1305
Cited by 269

Related Papers

CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
|Journal of Clinical Investigation|2017|159
Gefitinib induces myeloid differentiation of acute myeloid leukemia
|Blood|2005|127
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
|Journal of Clinical Investigation|2012|104
Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma
|Oncotarget|2015|98
Targeting serine hydroxymethyltransferases 1 and 2 for T-cell acute lymphoblastic leukemia therapy
|Leukemia|2021|58